Not applicableNot Yet RecruitingNCT04477876
What this trial is testing
Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?
Who this might be right for
Melanoma
Assistance Publique - Hôpitaux de Paris 55
Showing 3 of 3 results